Patient reported outcomes can improve performance status assessment: a pilot study

BackgroundPatient performance status is routinely used in oncology to estimate physical functioning, an important factor in clinical treatment decisions and eligibility for clinical trials. However, validity and reliability data for ratings of performance status have not been optimal. This study recruited oncology patients who were about to begin emetogenic palliative or adjuvant chemotherapy for treatment of solid tumors. We employed actigraphy as the gold standard for physical activity level. Correspondences between actigraphy and oncologists’ and patients’ ratings of performance status were examined and compared with the correspondences of actigraphy and several patient reported outcomes (PROs). The study was designed to determine feasibility of the measurement approaches and if PROs can improve the accuracy of assessment of performance status.MethodsOncologists and patients made performance status ratings at visit 1. Patients wore an actigraph and entered weekly PROs on a smartphone app. Data for days 1–14 after visit 1 were analyzed. Chart reviews were conducted to tabulate all unexpected medical events across days 1–150.ResultsNeither oncologist nor patient ratings of performance status predicted steps/hour (actigraphy). The PROMIS® Physical Function PRO (average of Days 1, 7, 14) was associated with steps/hour at high (for men) and moderate (for women) levels; the PROMIS® Fatigue PRO predicted steps for men, but not for women. Unexpected medical events occurred in 57% of patients. Only body weight in female patients predicted events; oncologist and patient performance status ratings, steps/hour, and other PROs did not.ConclusionsPROMIS® Physical Function and Fatigue PROs show good correspondence with steps/hour making them easy, useful tools for oncologists to improve their assessment of performance status, especially for male patients. Female patients had lower levels of steps/hour than males and lower correlations among the predictors, suggesting the need for further work to improve performance status assessment in women. Assessment of pre-morbid sedentary behavior alongside current Physical Functioning and Fatigue PROs may allow for a more valid determination of disease-related activity level and performance status.

[1]  Sean D. Rundell,et al.  Case Studies from the Clinic: Initiating and Implementing Patient-Reported Outcome Measures , 2017, EGEMS.

[2]  Doerte U. Junghaenel,et al.  PROMIS Fatigue Item Bank had Clinical Validity across Diverse Chronic Conditions. , 2016, Journal of clinical epidemiology.

[3]  J. Daurès,et al.  Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Karnofsky,et al.  The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .

[5]  Tim Olds,et al.  The validity of consumer-level, activity monitors in healthy adults worn in free-living conditions: a cross-sectional study , 2015, International Journal of Behavioral Nutrition and Physical Activity.

[6]  Megan C. Janke,et al.  Modeling Change in Older Adults' Leisure Activities , 2006 .

[7]  L. Sharples,et al.  Performance status score: do patients and their oncologists agree? , 2003, British Journal of Cancer.

[8]  Kathryn Sandberg,et al.  How consumer physical activity monitors could transform human physiology research. , 2017, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  H. Hansen,et al.  Performance status assessment in cancer patients. An inter-observer variability study. , 1993, British Journal of Cancer.

[10]  D. Cella,et al.  New English and Spanish social health measures will facilitate evaluating health determinants. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[11]  Amy P Abernethy,et al.  Review of electronic patient-reported outcomes systems used in cancer clinical care. , 2014, Journal of oncology practice.

[12]  Y Ohno,et al.  Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer , 2001, British Journal of Cancer.

[13]  J. Fries,et al.  The PROMIS Physical Function item bank was calibrated to a standardized metric and shown to improve measurement efficiency. , 2014, Journal of clinical epidemiology.

[14]  J. Fleiss Statistical methods for rates and proportions , 1974 .

[15]  Catrine Tudor-Locke,et al.  Utility of Pedometers for Assessing Physical Activity , 2004, Sports medicine.

[16]  W. Grove Statistical Methods for Rates and Proportions, 2nd ed , 1981 .

[17]  Murielle Mauer,et al.  Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. , 2009, The Lancet. Oncology.

[18]  R. Hays,et al.  Validity of PROMIS physical function measured in diverse clinical samples. , 2016, Journal of clinical epidemiology.

[19]  Catrine Tudor-Locke,et al.  Utility of Pedometers for Assessing Physical Activity , 2002 .

[20]  T. Hastie,et al.  Accuracy in Wrist-Worn, Sensor-Based Measurements of Heart Rate and Energy Expenditure in a Diverse Cohort , 2016, bioRxiv.

[21]  K. Ferraro,et al.  Obesity and Hospitalization over the Adult Life Course: Does Duration of Exposure Increase Use?∗ , 2007, Journal of health and social behavior.

[22]  M Benjamin Nelson,et al.  Validity of Consumer-Based Physical Activity Monitors for Specific Activity Types. , 2016, Medicine and science in sports and exercise.

[23]  D. Tulsky,et al.  Understanding Health-Related Quality of Life of Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Social Health Measures. , 2019, Archives of physical medicine and rehabilitation.

[24]  N. Carlozzi,et al.  Understanding Health-related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Mental Health Measures. , 2019, Archives of physical medicine and rehabilitation.

[25]  N. Pedersen,et al.  Gender Differences in Longitudinal Trajectories of Change in Physical, Social, and Cognitive/Sedentary Leisure Activities , 2018, The journals of gerontology. Series B, Psychological sciences and social sciences.

[26]  E. McFadden,et al.  Toxicity and response criteria of the Eastern Cooperative Oncology Group , 1982, American journal of clinical oncology.

[27]  L. Traeger,et al.  Actigraphy as an objective measure of performance status in patients with advanced cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Sloan,et al.  Patient‐physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer , 2008, Cancer.

[29]  N. Volkow,et al.  Physical activity measured with wrist and ankle accelerometers: Age, gender, and BMI effects , 2018, PloS one.

[30]  Daniel J Buysse,et al.  Development of Short Forms From the PROMIS™ Sleep Disturbance and Sleep-Related Impairment Item Banks , 2012, Behavioral sleep medicine.

[31]  G. Cardon,et al.  Reliability and validity of three questionnaires measuring context-specific sedentary behaviour and associated correlates in adolescents, adults and older adults , 2015, International Journal of Behavioral Nutrition and Physical Activity.

[32]  Ian N. Olver,et al.  Observer error in grading performance status in cancer patients , 1999, Supportive Care in Cancer.

[33]  N. Ohri,et al.  Tracking steps in oncology: the time is now , 2018, Cancer management and research.

[34]  Emil Frei,et al.  Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide , 1960 .